Appointment of Chief Financial Officer.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Brawn Biotech Ltd has appointed Ms. Rati Garg as the Chief Financial Officer and Key Managerial Personnel of the company, effective 1st February 2026. The appointment was made by the Board of Directors on 30th January 2026, based on the recommendation of the Nomination and Remuneration Committee. Ms. Rati Garg is a qualified Cost Accountant with over 15 years of experience in financial management, cost control, budgeting, regulatory compliance, FP&A, taxation, and corporate finance. The disclosure was made to BSE under SEBI Listing Regulations and SEBI Circular requirements.
The appointment of an experienced CFO with 15+ years in financial management and compliance is a routine governance update that may be viewed positively by investors as it strengthens the company's financial leadership. No immediate impact on stock price is expected from this administrative announcement.